Model
Edge
4D Molecular Therapeutics
0001834021
Filing Type
144
Filing Date
8/3/2026
Updated
8/4/26, 4:08 PM
Copy Ref
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities